Scientific Literature Search

Open access

Making Sense of … the Microbiome in Psychiatry.

Bastiaanssen TFS, Cowan CSM, Claesson MJ, Dinan TG, Cryan JF.

Int J Neuropsychopharmacol · 2019-01-01

DOI: 10.1093/ijnp/pyy067PMID: 30099552

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Effects of Exercise and Ferulic Acid on Alpha Synuclein and Neuroprotective Heat Shock Protein 70 in An Experimental Model of Parkinsonism Disease.

Askar MH, Hussein AM, Al-Basiony SF, Meseha RK, Metias EF, Salama MM, Antar A, El-Sayed A.

CNS Neurol Disord Drug Targets · 2019-01-01

DOI: 10.2174/1871527317666180816095707PMID: 30113007

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 1 : Dystonia, akathisia und parkinsonism].

Hirjak D, Kubera KM, Bienentreu S, Thomann PA, Wolf RC.

Nervenarzt · 2019-01-01

DOI: 10.1007/s00115-018-0582-5PMID: 30128734

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside.

Alborghetti M, Nicoletti F.

Curr Neuropharmacol · 2019-01-01

DOI: 10.2174/1570159x16666180830100754PMID: 30160213

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Neuroregeneration in Parkinson's Disease: From Proteins to Small Molecules.

Sidorova YA, Volcho KP, Salakhutdinov NF.

Curr Neuropharmacol · 2019-01-01

DOI: 10.2174/1570159x16666180905094123PMID: 30182859

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Neuroprotective Strategies for Neurological Disorders by Natural Products: An update.

Rehman MU, Wali AF, Ahmad A, Shakeel S, Rasool S, Ali R, Rashid SM, Madkhali H, Ganaie MA, Khan R.

Curr Neuropharmacol · 2019-01-01

DOI: 10.2174/1570159x16666180911124605PMID: 30207234

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review.

Costa IM, Lima FOV, Fernandes LCB, Norrara B, Neta FI, Alves RD, Cavalcanti JRLP, Lucena EES, Cavalcante JS, Rego ACM, Filho IA, Queiroz DB, Freire MAM, Guzen FP.

Curr Neuropharmacol · 2019-01-01

DOI: 10.2174/1570159x16666180911123341PMID: 30207235

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Traumatic Brain Injury Altered Normal Brain Signaling Pathways: Implications for Novel Therapeutics Approaches.

Rana A, Singh S, Sharma R, Kumar A.

Curr Neuropharmacol · 2019-01-01

DOI: 10.2174/1570159x16666180911121847PMID: 30207236

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein.

Pinho R, Paiva I, Jercic KG, Fonseca-Ornelas L, Gerhardt E, Fahlbusch C, Garcia-Esparcia P, Kerimoglu C, Pavlou MAS, Villar-Piqué A, Szego É, Lopes da Fonseca T, Odoardi F, Soeroes S, Rego AC, Fischle W, Schwamborn JC, Meyer T, Kügler S, Ferrer I, Attems J, Fischer A, Becker S, Zweckstetter M, Borovecki F, Outeiro TF.

Hum Mol Genet · 2019-01-01

DOI: 10.1093/hmg/ddy326PMID: 30219847

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Food Components with the Potential to be Used in the Therapeutic Approach of Mental Diseases.

Fernández MJF, Valero-Cases E, Rincon-Frutos L.

Curr Pharm Biotechnol · 2019-01-01

DOI: 10.2174/1389201019666180925120657PMID: 30255749

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Blood-Brain Barrier: From Physiology to Disease and Back.

Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV.

Physiol Rev · 2019-01-01

DOI: 10.1152/physrev.00050.2017PMID: 30280653

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Challenges in Defining Inappropriate Medication Use in Parkinson Disease Dementia.

Hess CW, Okun MS, Ramirez-Zamora A.

JAMA Neurol · 2019-01-01

DOI: 10.1001/jamaneurol.2018.2826PMID: 30285044

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

191.034 articles found

Making Sense of … the Microbiome in Psychiatry.

Effects of Exercise and Ferulic Acid on Alpha Synuclein and Neuroprotective Heat Shock Protein 70 in An Experimental Model of Parkinsonism Disease.

[Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 1 : Dystonia, akathisia und parkinsonism].

Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside.

Neuroregeneration in Parkinson's Disease: From Proteins to Small Molecules.

Neuroprotective Strategies for Neurological Disorders by Natural Products: An update.

Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review.

Traumatic Brain Injury Altered Normal Brain Signaling Pathways: Implications for Novel Therapeutics Approaches.

Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein.

Food Components with the Potential to be Used in the Therapeutic Approach of Mental Diseases.

Blood-Brain Barrier: From Physiology to Disease and Back.

Challenges in Defining Inappropriate Medication Use in Parkinson Disease Dementia.

Filters